Oct. 17, 2016

Hua Medicine Announces First-Ever Successful Phase 2 Monotherapy Trial for New Class of Diabetes Drug

Sep. 23, 2016

Hua Medicine Successfully Completes 12-week Phase 2 Trial of Novel GKA Diabetes Drug

Apr. 22, 2016

Hua Medicine Raises $50 Million Series C Financing in Oversubscribed Round

Aug. 11, 2015

Hua Medicine's GKA Diabetes Drug Demonstrates High Efficacy in 4-Week Phase 1c Trial

Mar. 10, 2015

Hua Medicine Files IND in US for Its Novel GKA-Based Diabetes Drug

Feb. 9, 2015

Hua Medicine Announces Positive Phase 1b Results in Diabetes With 4th-Generation Glucokinase Activator, Shows Robust 24-Hour Glucose Control

Jan. 8, 2015

Hua Medicine Raises $25 Million in Series B Financing to Start Phase 2 Trials

Mar. 19, 2014

Hua Medicine's Novel Glucokinase Activator Reports Positive Phase 1a Data Demonstrating Robust Glucose Regulatory Hormone Modulation & Commences Phase 1b Trials in Diabetes Patients

Dec. 20, 2011

Hua Medicine Licenses Novel Drug Candidate From Roche for Potential Treatment of Diabetes

Sep. 20, 2011

Hua Medicine Lands $50M Financing Commitment for China Biopharmaceutical Innovation, Development and Commercialization

Sep. 6, 2011

Hua Medicine T2D Drug Entered into Clinical Trial in China